18 February 2021

APLAR Biologics Conditions

Rationale behind ACR COVID vaccine guidelines

8 February 2021

Biologics COVID-19

Rheumatic disease and COVID-19 mortality

8 February 2021

Biologics Conditions

Medication review neglected in aged care

8 February 2021

Biologics Gout TGA

Tofacitinib safety for RA in doubt

3 February 2021

Biologics Spondyloarthritis

Can synovial biopsies predict RA treatment response?

27 January 2021

Biologics COVID-19

Gout drug for Covid gets press release treatment

18 December 2020

Biologics Spondyloarthritis

Gilead will not pursue FDA approval of filgonitib for RA

3 December 2020

Ankylosing Spondylitis Biologics Corticosteroids Juvenile Arthritis Medications

‘Absolutely invaluable’, ‘Big-Brother like’: ARA initiative sparks controversy

12 November 2020

Biologics Conditions

Even low-dose glucocorticoids have risks

2 October 2020

Analgesics Axial spondyloarthritis Biologics Conditions Gout Spondyloarthritis

Europe approves filgotinib despite FDA qualms

7 May 2020

Biologics

Govt relaxes PBS requirements for some medications

30 January 2020

Biologics Communicable Diseases Conditions

The long road to RA immunotherapy

30 January 2020

Biologics Conditions Gout

Upadacitinib gets TGA approval

30 January 2020

Biologics Conditions Gout

Let’s not overinterpret febuxostat study, author warns

4 December 2019

Biologics Conditions

Breaking down barriers on medical cannabis

24 October 2019

Analgesics Biologics Conditions

Rivaroxaban twice as likely to lead to clotting